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The clonal theory of immune selection predicts that,  during the differentia- 
tion of the immune system, clones of lymphocytes capable of recognizing "self," 
or autoantigens,  will be selectively eliminated; that the adult host will have no 
lymphocytes capable of self-recognition; and that the presence of autocytotoxic 
cells would not be anticipated (1). Evidence from murine models indicates that 
autocytotoxic cells do naturally occur, that they produce no demonstrable dis- 
ease in normal adult animals,  and that their reactivity can be demonstrated in 
vivo and  in  vitro  (2-7).  Autocytotoxic cells  can be detected  after  incubating 
normal spleen cells with irradiated fibroblasts under conditions of thymic defi- 
ciency [in vitro in fresh serum from thymectomized (TX) 1 animals  (3), in fetal 
calf serum (FCS) (4), or in heat-inactivated normal fresh mouse serum (3) or in 
vivo in TX mice (5)]. 
Human cytotoxic cells have been found in patients with a  variety of autoim- 
mune diseases using allogeneic cells as targets (8). Cells spontaneously cytotoxic 
for a variety of long-term solid tumor and lymphoblast tissue culture lines have 
been found in normal  individuals  (9,  10).  However, lymphocytes from normal 
individuals,  cytotoxic for short-term cultures of autologous or allogeneic fibro- 
blasts have not been described. 
We report here the presence of a naturally occurring subpopulation of human 
lymphocytes cytotoxic to autologous and allogeneic fibroblasts. Cytotoxicity was 
determined  by measuring  the  residual  radioactivity  of prelabeled  fibroblasts 
after overnight  incubation  with whole and partially purified lymphocyte sub- 
populations.  The  cytotoxic cell has characteristics  of neither  mature T  nor B 
lymphocytes. The tissue distribution and the target specificity of the autocyto- 
toxic cells are presented in this paper. 
Materials  and  Methods 
Fibroblast  Cultures.  Skin fibroblasts were obtained by punch biopsy from normal individuals 
and HLA  identical and mixed leukocyte culture-nonreactive (major histocompatibility region 
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[MHR] identical) bone marrow transplant donors and recipients. The biopsy was cut into l-ram 
sections which  were  put into 35-ram tissue culture dishes  (Falcon Plastics,  Div.  of BioQuest, 
Oxnard, Calif.) containing 0.05 ml FCS (Microbiological Associates, Bethesda, Md.) and covered 
with a  20  x  20 mm  cover slip.  30  min later,  1  ml of medium  RPMI-1640  with 20%  FCS  and 
glutamine (2 x  10  -~ M), and antibiotics (penicillin, 50 U/ml; streptomycin, 50 ftg/ml; kanamycin, 
50 ~tg/ml; and microstatin, 50 U/ml) was added. The fibroblast cultures were maintained at 37°C in 
a  5% CO2 incubator (National Appliance Co.,  Portland,  Oreg.),  and the medium was replaced 
weekly.  Fibroblasts, that had reached confluency, were washed once with Hanks' balanced salt 
solution (HBBS) and incubated for 10 rain in 0.25% trypsin (Grand Island Biological Co., Grand 
Island, New York). Fibroblasts were aspirated, centrifuged once at 200 g  for 10 rain, and resus- 
pended in Eagle's minimal essential medium (MEM) with 10% FCS and the aforementioned anti- 
biotics. 2  x  105 fibroblasts were planted in a  100 ml plastic tissue culture dish (Falcon Plastics, 
Div. of BioQuest). Fibroblasts were also suspended at 1 x  106/ml in MEM with 10% dimethylsul- 
fate (J. T. Baker Chemical Co.,  Phillipsburg, N. J.) and 20% FCS,  slowly frozen, and stored in 
liquid  N2.  All  experiments were  performed  with  fibroblasts between  the  6th and  12th tissue 
culture passage. 
Separation  and Preparation of Lymphocytes.  Peripheral blood was collected in preservative- 
free heparin (100 U/ml blood). Peripheral blood leukocytes were separated on gradients of Ficoll- 
Hypaque  (11),  and  the  interface  cells  collected  and  washed  in  HBSS.  The  cells  were  then 
resuspended at i  x  108 cells/ml in RPMI-1640 with 10% heat-inactivated human AB-positive serum 
with glutamine and antibiotics added (complete medium). Lymphocytes were either used immedi- 
ately or incubated overnight at 37°C in a  5% CO~ incubator and used the following day. 
Discontinuous gradients of bovine serum albumin (BSA) were prepared following the methods 
of Dicke et al.(12).  BSA (fraction V; Sigma Chemical Co., St.  Louis,  Mo.) was dissolved in Tris 
buffer, 0.155 M, pH 7.2, with a final concentration of 35% as determined by a Zeiss refractometer 
(Carl Zeiss, Inc., New York). The osmolarity, measured on a Fiske osmometer (Fiske Associates, 
Inc., Uxbridge, Mass.), was corrected to 360 mosmol with NaC1. The 35% BSA solution was diluted 
with phosphate-buffered saline (PBS), pH 7.1,  300 mosmol. Gradients were prepared in 12  ×  75 
mm tissue culture tubes (Falcon no. 2003; Falcon Plastics, Div. of BioQuest) by layering I ml of 33, 
27, and 22% BSA. 10-40  x  10  e cells in complete medium were layered on top of the gradient and 
centrifuged for 30 min at 1,000g at 4°C. The cells at each interface were collected, washed twice in 
HBSS, and resuspended at 1 x  10  e cells/ml in complete medium. 
Human gamma globulin was aggregated by heating at 60°C for 1 h (13). The washed aggregated 
gamma globulin was incubated at 1 mg/ml with 1 x  106 cells in complete medium for 1 h at 37°C. 
The cells were washed twice with HBSS and resuspended at 1 x  108 cells/ml in complete medium. 
Leucopak nylon (Fenwal Inc., Walter Kidde & Co., Inc., Morton Grove, Ill.) was washed for 1 
wk in sterile distilled water with frequent changes. 1 ml of the dried nylon wool was packed into 
10-ml syringes.  Before use,  the  nylon wool  was washed with 5  ml HBSS  and then with 5  ml 
complete medium.  The syringes were prewarmed to 37°C,  and 10  x  10  e lymphocytes in 1 ml of 
medium were pipetted on the nylon and incubated at 37°C for 45 min in a 5% CO2 incubator. The 
nonadherent cells were then slowly eluted with 10 ml of complete medium over a  5-10 rain period 
(14).  In some experiments, Ficell-Hypaque-separated ceils were rosetted with E  and EAC3 (15), 
and rosetted cells were  separated on gradients of Ficoll-Hypaque from nonrosetted cells which 
were resuspended at 1 x  108 cells/ml in complete medium. Surface immunoglobulin was detected 
on lymphocytes by staining with fluoresceinated monospecific rabbit anti-human IgG, IgM, and 
IgA (Behring Diagnostics, American Hoechst Corp., Somerville, N. J.) and counting under a Zeiss 
fluorescent microscope (Carl Zeiss, Inc.). 
Fibroblast Cytotoxicity Assay.  Noncenfluent fibroblast cultures were aspirated, washed with 
HBSS,  and then incubated with medium 199 deficient in leucine, iseleucine, valine, and lysine 
(GIBCO)  supplemented with  10%  FCS and an equimolar mixture of ]4C-amino acids  (leucine, 
isoleucine, valine, and lysine; sp act,  >270 mCi/mmol) (New England Nuclear, Cambridge, Mass.), 
i  mCi/100 mm tissue culture dish. After overnight incubation the dishes were washed with HBSS 
and the fibroblasts were trypsinized.  1,000 fibroblasts in 0.1 ml RPMI-1640 with 10% FCS were 
added to each well of a 96 well microtiter plate (Linbro Scientific, Hamden, Conn.). The microtiter 
plates were incubated overnight in the CO2 incubator to allow fibroblast attachment. 
The wells were then aspirated and 0.1 ml of complete medium was added to control wells and 1 
x  105 lymphocytes in 0.1 ml of complete medium was added to test wells. Tests were performed in 1522  A  SUBPOPULATION  OF  LYMPHOCYTES  IN  HUMAN  PERIPHERAL  BLOOD 
quadruplicate  with  two  fibroblast  lines  as  targets.  The  plates  were  incubated  on  a  rocking 
platform (Bellco Glass, Inc., Vineland, N. J.) 4-5 cycles/min at 37°C in a 5% COz incubator. After 
overnight incubation, the plates were emptied by inversion, washed three times with HBSS with 
inversion, fixed with ice-cold methanol for 10 rain, and then air dried.  Plates were sprayed; the 
bottom of the wells were punched into counting vials and assayed for ~4C in a liquid scintillation 
counter (Model 3320; Packard Instrument Co., Downers Grove, Ill.). Results were expressed as a 
mean percentage  _+  1  standard  deviation of the  residual  radioactivity  found  in  control  wells 
incubated with medium alone. Residual radioactivity of less than 80%, when compared to medium 
controls (100%),  was considered significant. 
Results 
Fibroblast  Cytotoxicity of Whole and Fractionated  Human Peripheral Blood 
Lymphocytes.  The capacity of Ficoll-Hypaque-separated peripheral blood lym- 
phocytes to lyse autologous,  histo-identical  (MHR), and allogeneic skin fibro- 
blasts is presented in Fig.  1. The mean percentage of residual radioactivity of 
autologous, MHR identical,  and allogeneic lymphocyte-fibroblast combinations 
were 100.8,  101.3, and 96.6%. The standard deviation for control fibroblast wells 
was 9-10%. Residual radioactivity of less than 80%, a decrease of greater than 2 
standard  deviations,  was  considered  to represent  significant  cytotoxicity.  No 
autologous or MHR identical lymphocyte-fibroblast combination demonstrated 
significant cytotoxicity. Only one allogeneic-lymphocyte fibroblast combination 
demonstrated a significant decrease in residual radioactivity (69.1%).  On repeat 
testing,  this deviant combination fell within the normal range.  The allogeneic 
combinations represent 11 individuals tested against 10 different fibroblast lines 
over a  9 mo period. 
Peripheral  blood leukocytes were fractionated on discontinuous gradients of 
BSA and designated fraction 1, ---22% BSA; fraction 2, 22-27% BSA; and fraction 
3, 27-33% BSA. 10-15% of the lymphocytes were found in fraction 1, 60-80% in 
fraction 2, and 5-10% in fraction 3. Total cell yield was 60-90%. 
Fig. 2 shows the cytotoxicity of unfractionated and BSA-fractionated lympho- 
cytes assayed on autologous fibroblasts. The unfractionated  (103.8%)  and frac- 
tion  1  (88.6%)  lymphocytes demonstrate  no  significant  cytotoxicity,  whereas 
fraction 2 (38.1%) and fraction 3 (68.5%)  cells produce significant lysis. Cytotox- 
icity to autologous fibroblasts was detected in fraction 2 lymphocytes from four 
of six  normal  individuals,  while  their  unfractionated  lymphocytes  were  not 
cytotoxic (Table I). 
When  BSA-fractionated  lymphocytes from  normal  individuals  were tested 
against two or more allogeneic fibroblast lines, fraction 2 lymphocytes from 8 of 
11 individuals lysed one or more allogeneic fibroblast lines.  Lymphocytes from 
three individuals lysed only one of two allogeneic fibroblast targets  (Table II), 
whereas five others lysed two or more target cell lines. 
A semilogarithmic dose-response curve was obtained with fractionated cyto- 
toxic  allogeneic  lymphocyte-fibroblast  combinations  (Fig.  3).  Unfractionated 
lymphocytes at a  100:1 lymphocyte:fibroblast ratio  were noncytotoxic  (96.7  __+_ 
7.9%)  while fraction 2 cells, which represented 94% of the cells recovered after 
fractionation  (total yield, 67%) were cytotoxic at a  100:1 ratio with only 28.1  _+ 
3.7% of the radioactivity remaining.  Significant cytotoxicity was seen at ratios 
as low as 25:1 (64.1  _  4.3%) but significant cytotoxicity was not usually detected 
at a ratio of less than 50:1. ROBERTSON  PARKMAN  AND  FRED  S.  ROSEN  1523 
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F,G.  2.  Residual radioactivity of autologous fibroblasts after overnight incubation with 
unfractionated and BSA-fractionated lymphocytes. Shaded area represents normal range. 
Unfractionated lymphocytes incubated with 33% BSA, Tris buffer, or BSA in 
PBS  for 30  min and  then processed  as  usual,  displayed no  cytotoxicity. To 
determine if the cytotoxicity was directed toward membrane antigens acquired 
from the heterologous FCS fibroblasts were grown in human serum for two cell 
passages (10 days) before use as target cells. The degree oflysis of cells grown in 1524  A  SUBPOPULATION  OF  LYMPHOCYTES  IN  HUMAN  PERIPHERAL  BLOOD 
TABLE  I 
In Vitro Cytotoxicity of Unfractionated and BSA Gradient Fractionated Peripheral 
Blood Lymphocytes Tested against Autologous Fibroblasts 
Age of  do- 
Unfractionated 
nor 
Effector cell 
Fraction 1  Fraction 2  Fraction 3 
yr  % Residual radioactivity  +_ 1 SD 
12  99.7  _+ 13.4  99.2  _+ 2.0  66.0-  +  7.0  89.9  _+ 9.6 
15  106.7  _+ 6.4  88.5  -+ 2.4  38.2  _+ 7.6  66.2  _+ 3.9 
15  86.3  _+ 16.6  74.7  +  2.5  50.6  -  6.0  101.6  ±  23.5 
3  85.5 ±  7.5  105.4  ±  9.4  75.1  -+ 7.7  93.1  ___ 2.4 
9  112.9  -+ 7.8  113.0  ±  4.0  82.2  _+ 9.4  96.9 _  12.1 
45  113.7  ±  18.4  110.3  _+ 6.5  114.4  _  16.2  98.9  _+ 9.4 
Ficoll-Hypaque-separated peripheral blood lymphocytes fractionated on discontinuous BSA gra- 
dients; fractionated and unfractionated lymphocytes were suspended in RPMI-1640 medium with 
10% AB + serum. Lymphocytes were assayed overnight at a 100:1 ratio with 1 × 103 ~4C-amino acid- 
prelabeled autologous fibroblasts in microtiter tissue culture plates. Plates were incubated at 37°C 
in a  CO2 incubator on a rocking platform, 4-5 cycles/min. The plates were washed three times in 
HBSS, fixed, and the residual radioactivity determined. Experiments were performed in quadru- 
plicate and results expressed as mean _+ SD.  100% equals residual radioactivity in control wells 
incubated with medium alone. Unlined values represent significant cytotoxicity. 
TABLE  II 
Cytotoxicity of Unfractionated and Fractionated Lymphocytes against 
Allogeneic Fibroblasts 
Effector cells 
Target fibroblasts 
Allogeneic- 1  Allogeneic-2 
% Residual radioactivity  +- 1 SD 
Unfractionated  83.5  -  12.2  120.2  ±  9.6 
Fraction 1  107.2  -+ 16.9  100.8  ±  7.0 
Fraction 2  42.4  _+ 5.1  102.4  -+ 5.9 
Fraction 3  61.8  -  14.0  105.2  ±  11.3 
Ficoll-Hypaque- and BSA-fractionated peripheral blood lymphocytes were incubated 
at 100:1 ratio with 14C-amino acid prelabeled allogeneic fibroblasts, 1,000 fibroblasts/ 
well in microtiter plates. The plates were incubated overnight at 37°C on a  rocking 
platform, 4-5 cycles/rain. The wells were washed three times with HBSS, fixed, and 
the residual radioactivity determined. Experiments were performed in quadruplicate 
and results expressed as a  mean percentage of control wells  -+ 1 SD.  100%  equals 
residual radioactivity in wells with medium alone. 
AB+  serum  and  medium  was  equal  to,  or  greater  than,  cells  grown  in  FCS. 
Human  AB+  serum  from  nontransfused  normal  blood  donors,  predominantly 
males,  was  routinely  used  in  the  cytotoxic  assay.  The  use  of different  lots  of 
AB+  serum,  or  autologous  serum,  did  not  alter  the  fraction  2  lymphocyte 
cytotoxicity. 
Relation  of Fibroblast  Cytotoxicity  to the MHR.  To  determine  if the  target 
fibroblast  antigen  was  linked  to  the  MHR,  fibroblasts  were  established  from 
MHR  identical  siblings;  whole  and  fractionated  lymphocytes  were  tested.  Table 
III  shows  the  results  with  the  lymphocytes  of  one  of  three  MHR  identical 
brothers  tested  against  autologous,  MHR  identical,  and one allogeneic  fibroblast ROBERTSON  PARKMAN  AND  FRED  S.  ROSEN  1525 
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FIG.  3.  Dose-response  curve  of unfractionated  (U)  and  fraction  2  lymphocytes  tested 
against allogeneic fibroblasts. 
TABLE  III 
Relationship  of Fibroblast  Cytotoxicity to MHR of Target Cells 
Effector cells 
Target fibroblast 
Autologous  MHR identical-1  MHR identical-2  Altogeneic 
% Residual  radioactivity  +- SD 
Unfractionated  99.7  _+  13.4  86.0  +  14.2  92.4  -  15.1  96.3  -+  13.8 
Fraction  1  99.2  _+  2.0  96.3  +  7.7  96.7  -+ 3.0  108.7  _  29.3 
Fraction 2  66.0  _  7.0  81.7  _+  5.2  74,4  -+  11.0  59.6  _+  12.3 
Fraction 3  89.9  +_ 9.6  100.7  _+  14.1  105.7  _+ 9.9  96.9  -  16.4 
BSA Control  97.2  +_  13.3  105.3  _+  12.5  103.9  -+ 5.4  103.7  _+  14.4 
Peripheral  blood  leukocytes  were  separated  in  Ficoll-Hypaque  gradients.  They  were  further 
fractionated on discontinuous BSA gradients or mixed with 33% BSA for 45 min. The unfraction- 
ated,  BSA  fractionated,  and  BSA  treated  were  resuspended  in  RPMI  1640  with  10%  heat- 
inactivated human  AB and serum at 1  ×  106 cells/ml and assayed at a  100:1 ratio with 1,000 14C- 
amino acid-prelabeled  fibroblasts in microtiter  II plates.  Experiments were performed in tripli- 
cate; the plates were incubated on a rocking platform, 4-5 cycles/min in a  5% CO2 incubator at 37°C 
overnight, washed three times with HBSS, and fixed with cold methanol. The residual radioactiv- 
ity determined in a  liquid scintillation counter. 100% equals the residual radioactivity present in 
wells incubated with medium alone. Results expressed as the mean percentage of control wells -+1 
SD.Unlined values represent significant cytotoxicity. 
line. Fraction 2 lymphocytes significantly lysed autologous (66.0%), allogeneic 
(59.6%) and one MHR identical (MHR-2) fibroblast line (74.4%). A second MHR 
identical line (MHR-1) was not significantly lysed (81.7%). 
Absorption studies were undertaken to determine the relationship between 
the antigens expressed by autologous and MHR identical fibroblasts and alloge- 
neic fibroblasts. Fraction 2 lymphocytes were incubated for 6 h on MHR-1 and 1526  A  SUBPOPULATION  OF  LYMPHOCYTES  IN  HUMAN  PERIPHERAL  BLOOD 
TABLE  IV 
Effect of Fibroblast Absorption on Cytotoxicity of Fraction 2 Lymphocytes 
Fraction 2 lymphocyte 
treatment 
Target fibroblast 
Autologous  MHR identical-1  MHR identical-2  Allogeneic 
% Residual  radioactivity  +_ 1 SD 
None  66.0  _+  7.0  81.7  -+ 5.2  74.4  _+  11.0  59.6  -  12.3 
Absorption  on  MHR-1  89.0  _+  7.9  90.6  +-  1.4  84.6  ±  14.7  65.3  -  20.0 
fibroblasts 
Absorption  on  MHR-2  95.8  ±  7.1  96.2  -+  12.9  108.4  ±  2.0  64.4  _+  20.6 
fibroblasts 
Fraction 2 lymphocytes in AB+ medium incubated on confluent flbroblast monolayers for 6 h. The 
nonadherent  cells  were  collected,  washed,  and  assayed in  the  standard  fibroblast  cytotoxicity 
assay. Unlined values represent significant cytotoxicity. 
MHR-2 fibroblasts;  the  nonadherent  cells  were collected and  assayed on the 
target fibroblasts (Table IV). After absorption on MHR-2 fibroblasts, the nonad- 
herent cells exhibited no cytotoxicity toward autologous (95.8%) and the MHR-2 
(108.4%) fibroblasts but still lysed the allogeneic fibroblasts (64.4%). The MHR-1 
fibroblasts, which were not significantly lysed initially, also removed the cyto- 
toxicity directed towards the autologous (89.0%)  and MHR-2 (84.6%)  fibroblast 
lines. The decrease in cytoxicity ai~r fibroblast absorption was not a nonspecific 
effect since significant cytotoxicity of the allogeneic fibroblasts was still present 
in both cases. Both histo-identical fibroblast lines express antigens that specifi- 
cally remove lymphocytes cytotoxic to themselves and the autologous fibroblasts 
but not to the allogeneic fibroblasts. 
Surface Characteristics of the Fibroblast Cytotoxic Cell.  To determine if the 
lymphocytes responsible for fibroblast cytotoxicity were either  mature T  or B 
lymphocytes,  Ficoll-Hypaque-separated  lymphocytes were rosetted  with  E  or 
EAC3  cells  and  the  nonrosette-forming  cells  fractionated  on  BSA gradients. 
Control and rosette-depleted lymphocytes were then assayed on the same alloge- 
neic target fibroblasts (Table V). Removal of EAC3 rosette-forming cells signifi- 
cantly reduced the cytotoxicity of fraction 2 lymphocytes (72.5 ---> 106.9) whereas 
removal of E-rosetting lymphocytes had no significant effect on the cytotoxicity 
of fraction 2 cells. Passage of reactive fraction 2 cells through nylon wool (yield 
60%) increased the reactivity of the passaged cells (Table VI, exps. 1 and 2). The 
increase in cytotoxicity was specific since the passage of noncytotoxic fraction 2 
cells did not increase their cytotoxicity (exp. 3).  The nylon-passed cells had a 
markedly reduced number of immunoglobulin-bearing  cells (<3%).  Preincuba- 
tion  of cytotoxic fraction  2  lymphocytes with  1 mg/ml  of aggregated  gamma 
globulin before assay completely inhibited their cytotoxicity for fibroblasts. 
Tissue Distribution of Fibroblast Cytotoxic Cells.  Tonsils from normal chil- 
dren (2- to 5-yr old) demonstrated no fibroblast cytotoxicity even after fractiona- 
tion; thymocytes from children,  6-mo to 2-yr old, were also noncytotoxic (Table 
VII). 
The peripheral blood leukocytes of three patients with X-linked agammaglob- 
ulinemia were assayed on allogeneic target fibroblast lines. These patients have 
an absence of mature B cells in both their peripheral blood and bone marrow. 
Neither whole nor BSA-fractionated cells demonstrated any cytotoxicity. ROBERTSON  PARKMAN  AND  FRED  S.  ROSEN  1527 
TABLE  V 
Effect of Rosette Depletion on Fibroblast Cytotoxicity 
E-rosette formation  EAC3-rosette formation 
Control  E Depleted  Control  EAC3-Depleted 
Unfractionated  87.1 -* 10.2  84.0 ± 9.4  NS*  85.6 ~  17.0  123.1 ±  7.6  P  = 0.05 
Fraction 1  81.7 +- 13.4  78.1 _+ 5.0  NS  104.3 -* 2.7  ND$  - 
Fraction 2  50.9 _+ 2.4  55.7 _* 5.7  NS  72.5 -* 11.1  106.9 _+ 2.8  P  = 0.02 
Fraction 3  60.4 _* 6.1  80.6 _* 8.5  P  = 0.05  84.8 _+ 7.4  108.1  NS 
Unfractionated peripheral blood lymphocytes  rosetted with E or EAC3 cells, and the nonrosetted and control cells fractionated on 
the standard BSA gradients. Unfractionated and fractionated cells were then assayed against allogeneic fibreblast targets. 
* NS, not significant. 
ND, not done. 
TASLE VI 
Effect of Nylon Passage on the Fibroblast Cytotoxicity of Fraction 2 Lymphocytes 
Treatment  Exp.  1  Exp.  2  Exp.  3 
% Residual radioactivity  +_ 1 SD 
None  75.5  -  9.2  77.3  -+  6.9  83.9  +-  16.9 
Nylon  passed  20.3  +-  5.8  17.9  _+  2.2  90.5  _+  4.7 
10 ×  108 Fraction  2 lymphocytes  were  incubated  with  I  ml of washed  nylon  for 45 min  at 37°C. The 
eluted  and  control  cells were  then  assayed  on allogeneic  fibroblast  targets. 
TABLE  VII 
FibroblastCytotoxici@  ofLymphocytesfrom  Thymus and Tonsils 
Fibroblast-I  Fibroblast-2 
% Residual radioactivity 
Thymocytes 
Unfractionated  119.0  _+  20.0  121.8  _+  6.0 
Fraction  1  102.8  _+  6,6  108.6  -+  4.8 
Fraction  2  107.8  +_  24.4  105.7  -+  5.3 
Fraction  3  108.2  -  3.6  107.2  _+  3.0 
Tonsillar  leukocytes 
Unfractionated  92.0  _+  7.6  100.6  -+  6.0 
Fraction  1  108.1  _+  19.6  100.3  _+  8.0 
Fraction  2  98.0  _+  15.5  94.7  _+  9.6 
Fraction  3  103.9  -  12.4  85.3  _+  10.0 
Single  cell  suspensions  of tonsils  and  thymus  were  fractionated  on BSA  gradients; 
fractionated  and  unfractionated  lymphocytes  were  then  assayed  on allogeneic  fibro- 
blast  targets. 
Discussion 
Unfractionated  peripheral  blood leukocytes from  normal  individuals  were 
noncytotoxic to established human  fibroblast lines  of autologous or isologous 
origin and rarely cytotoxic to allogeneic cells. After fractionation  on discontin- 
uous gradients of BSA, a fraction of medium density cells (fraction 2) from 8 of 11 
individuals were cytotoxic for autologous, MHR identical,  and some allogeneic 
fibroblasts. The cytotoxicity was not due to monocytes nonspecifically activated 
by the separation procedures since fractionated peripheral blood leukocytes from 
some normal individuals and from patients with X-linked agammaglobulinemia 
were noncytotoxic. The specificity of target destruction displayed by fraction 2 
cells from normal individuals (Table III) minimizes the significance of alteration 1528  A  SUBPOPULATION  OF  LYMPHOCYTES  IN  HUMAN  PERIPHERAL  BLOOD 
of the  targets  by the  acquisition  of infectious  agents  (pleuropneumonia-like 
organisms or viruses) or by the adsorption of heterologous serum antigens.  The 
use of AB+ serum from untransfused male donors excludes the possibility that 
the cytotoxicity is due to the presence of antibodies to histocompatible antigens. 
Naturally occurring human cells, spontaneously cytotoxic for long-term lym- 
phoblast and solid tumor tissue culture lines,  have been described (9,  10) and 
may,  in  some  cases,  be  due  to  acquired  heterologous  serum  antigens  (16). 
Experiments with short-term  allogeneic or autologous fibroblast cultures have 
shown no cytotoxicity and have been used as control for tumor-specific cytotoxic- 
ity (17).  The presence in peripheral  blood of lymphocytes that are cytotoxic to 
autologous and allogeneic fibroblasts have not been previously reported. 
The  absorption  experiments  demonstrate  that  the  target  specificity of the 
autocytotoxic cells are antigens broader than those expressed on the autologous 
fibroblasts.  The  antigens  expressed  on  autologous  fibroblasts  are  present  on 
histo-identical fibroblasts (Table IV); however, it is not possible to determine if 
they are linked to the MHR. Removal of autologous reactivity by histo-identical 
fibroblasts does not effect the lysis of allogeneic fibroblasts. Thus, the cytotoxic- 
ity cell is "sensitized" to alloantigens as well as to autoantigens. 
The autocytotoxic cells producing fibroblast lysis have the characteristics of 
neither mature T nor B lymphocytes. Although the cytotoxic cells are recovered 
from fraction 2 of the BSA gradients,  which is composed primarily of mature T 
lymphocytes, they are not removed by E-rosette formation nor are they present 
in thymus; thus, they are not T lymphocytes. The autocytotoxic cells also appear 
not  to be mature  B  lymphocytes since they are  not found primarily  in  BSA 
gradient fraction 3, where B lymphocytes predominate (18), nor are they present 
in normal tonsils which contain significant numbers of B lymphocytes. Further 
passage of reactive fraction 2 cells through nylon (Table VI), which significantly 
reduces the number of immunoglobulin-bearing cells (10% --* <3%), rather than 
decreasing the fibroblast cytotoxicity, which would be expected if the reactive 
cell  were a  B  lymphocyte,  actually increased  fibroblast cytotoxicity. They do 
have a receptor for C3. The possibility that the cells are nonadherent cells of the 
monocyte-macrophage  series appears  remote due to the target  specificity dis- 
played.  Experiments  with  aggregated  human  gamma  globulin  have  shown 
inhibition  of cytotoxicity, suggesting that the cell expresses an Fc receptor. 
The absence of cytotoxic cells in the peripheral blood of three patients with X- 
linked agammaglobulinemia  and their absence of mature B lymphocytes may 
indicate that the autocytotoxic cell is a precursor B lymphocyte, missing in the 
patients (18). Thus, the cell responsible for the fibroblast cytotoxicity appears to 
be a  lymphocyte but cannot be classified as a  mature T or B lymphocyte. 
Autocytotoxic cells  were  found  in  the  peripheral  blood  of the  majority  of 
normal  adults.  They were not found  in  the  thymus  or tonsils  assayed; their 
absence may indicate that  the  cytotoxic cells are found predominantly  in the 
peripheral circulation and not in the fixed lymphoid organs. 
The cytotoxicity displayed by fraction 2 lymphocytes can not be due to concen- 
tration  effects alone.  Fraction 2 represents 60-80% of the total recovered cells; 
however, the increase in cytotoxicity cannot be explained by the minor increase 
(20-50%) in the concentration of fraction 2 cells. Doubling of the concentration of 
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The possibility was considered that the fractionation procedures separated the 
autocytotoxic cells from a minor population of lymphocytes  that "regulated" the 
cytotoxic cells.  Experiments in which cytotoxic fraction 2 cells were incubated 
overnight with fraction  1,  fraction 3,  and unfractionated cells demonstrated 
varying degrees of inhibition when fraction 1, but not fraction 3 or unfraction- 
ated cells, were added. Not all normal individuals gave reproducible inhibition, 
however. Further work is underway concerning the nature of the "regulator" 
cells. 
The surface characteristics of the murine cells,  autocytotoxic to syngeneic 
fibroblasts, have not been well described. Preliminary evidence (M. Osband and 
R. Parkman, unpublished observations) indicate that the murine autocytotoxic 
cell has a medium density in BSA gradients, expresses no 0, and is nylon wool 
nonadherent. The human and murine autocytotoxic cells, therefore, have many 
surface characteristics in common. 
Cytotoxicity of syngeneic murine target cells by unfractionated spleen cells 
has been described in mice after viral  infection (19). If the "regulator" and 
cytotoxic cells are in balance in the normal spleen and if the virus challenge 
selectively and temporarily decreases the number of regulator cells, the relative 
excess of the  autocytotoxic cells  would  be  detected by the  in  vitro  lysis  of 
syngeneic fibroblasts. 
Because of  the similarities between the human autocytotoxic lymphocytes  and 
the murine models,  active thymic humoral factor (THF)  extracted from calf 
thymus, which blocked the sensitization of murine autocytotoxic cells (4), was 
added to human fraction 2 lymphocytes  during the fibroblast assay. No decrease 
in fibroblast cytotoxicity was observed. THF does not inhibit murine autocyto- 
toxic cells once they have become "sensitized." The human autocytotoxic cell 
may not be sensitive to the action of THF or may be already sensitized when the 
THF  was  added  to  the  cultures.  Experiments are  underway to  define the 
possible role of thymic hormones in the control of the human autocytotoxic cells. 
If thymic humoral control is important, increasing host age with its concomitant 
decrease in thymic function may be a  possible explanation for the observed 
increase in human "autoimmune" diseases seen with advancing age. 
Summary 
A naturally occurring subpopulation of human peripheral blood lymphocytes 
is cytotoxic to autologous and/or allogeneic fibroblasts. The autocytotoxic lym- 
phocytes have a receptor for the third component of complement and for aggre- 
gated gamma globulin, do not form rosettes with sheep red blood cells, and are 
not removed by passage through nylon. The autocytotoxic subpopulation is not 
present in the thymus and tonsils of normal children or in the peripheral blood 
of individuals with X-linked agammaglobulinemia. Fibroblast absorption ex- 
periments demonstrate that the autocytotoxic cells are "sensitized" to antigens 
expressed on allogeneic fibroblasts in addition to the antigens expressed on 
autologous  cells.  Some  normal  individuals  have  a  second  subpopulation  of 
lymphocytes  that may "regulate" the autocytotoxic cells. The relevance of these 
observations to the murine autocytotoxic cells is discussed. 
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